Update on Gene Therapy Clinical Trials for Choroideremia and Potential Experimental Therapies
<i>Background and objectives</i>: Choroideremia (CHM) is an X-linked recessive chorioretinal dystrophy caused by mutations involving the <i>CHM</i> gene. Gene therapy has entered late-phase clinical trials, although there have been variable results. This review gives a summary on the outcomes of pha...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2021-01-01
|
| Seri Bilgileri: | Medicina |
| Konular: | |
| Online Erişim: | https://www.mdpi.com/1648-9144/57/1/64 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|